Risk factors for the development of severe typhoid fever in Vietnam

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Parry, Christopher M ^a,b   Thompson, Corinne ^a,c   Vinh, Ha ^d   Chinh, Nguyen T ^d   Phuong, Le T ^e   Ho, Vo A ^e   Hien, Tran T ^a,d   Wain, John ^a,f   Farrar, Jeremy J ^a,c   Baker, Stephen ^a,c,g  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e Dong Thap Provincial Hospital   (Viet Nam)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antimicrobial resistance; Intermediate ciprofloxacin susceptibility; Multidrug resistance; Salmonella enterica serovar Typhi; Severe typhoid

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BRAIN DISEASE; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FATALITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; OUTCOME ASSESSMENT; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SHOCK; TYPHOID FEVER; VIET NAM;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; SALMONELLA TYPHI; SEVERITY OF ILLNESS INDEX; TYPHOID FEVER; VIETNAM; YOUNG ADULT;

EID: 84893666370     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-73     Document Type: Article

References (42)

1. Buckle GC, Fischer Walker CL, Black RE. Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010. J Global Health 2012, 2:010401.
2. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, Actinic MD, Bhutta ZA, Cahn DG, Ali M, Shin S, Wain J, Page AL, Albert MJ, Farrar J, Abu-Elated R, Pang T, Galindo CM, von Seidlein L, Clemens JD. DOMI study typhoid group. A study of typhoid fever in five Asian countries: disease burden and implications for control. Bull WHO 2008, 86:260-268. 2647431, 18438514.
3. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. New Engl J Med 2002, 347:1770-1782. 10.1056/NEJMra020201, 12456854.
4. Butler T, Knight J, Nath SK, Speelman P, Roy SK, Azad MAK. Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis 1985, 7:244-256. 10.1093/clinids/7.2.244, 3890097.
5. Van den Bergh ETAM, Gasem MH, Keuter M, Dolmans MV. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Trop Med Int Health 1999, 4:211-215. 10.1046/j.1365-3156.1999.43374.x, 10223217.
6. Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996, 75:214-217. 10.1136/adc.75.3.214, 1511710, 8976660.
7. Butler T, Islam A, Kabir I, Jones PK. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalised patients with diarrhoea. Rev Infect Dis 1991, 13:85-90. 10.1093/clinids/13.1.85, 2017639.
8. Chau TT, Campbell JI, Galindo CM, Hoang NVM, Diep TS, Nga TTT, Vinh Chau NV, Tuan PQ, Page AL, Ochiai L, Schultsz C, Wain J, Bhutta ZA, Parry CM, Bhattacharya SK, Dutta S, Agtini M, Dong B, Honghui Y, Anh DD, Canh DG, Naheed A, Albert MJ, Phetsouvanh R, Newton PN, Basnyat B, Arjyal A, La TTP, Rang NN, Phuong LT, Bay PVB, von Seidlein L, Dougan G, Clemens JD, Vinh H, Hien TT, Chinh NT, Acosta CJ, Farrar J, Dolecek C. Antimicrobial drug resistance of Salmonella enteric serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 2007, 51:4315-4323. 10.1128/AAC.00294-07, 2167998, 17908946.
9. Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Stevenson J, Medalla F, Barzilay E, Joyce K, Barrett T, Mintz ED. Typhoid fever in the United States, 1999-2006. JAMA 2009, 302:859-865. 10.1001/jama.2009.1229, 19706859.
10. Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, Segler SD, Megginson M, Luedeman LJ, Shiferaw B, Hanna SS, Joyce KW, Mintz ED, Angulo FJ. Emerging Infection Program FoodNet, NARMS Working Group: Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multicentre retrospective cohort study. Antimicrob Agents Chemother 2008, 52:1278-1284. 10.1128/AAC.01509-07, 2292528, 18212096.
11. Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, Hien TT, Farrar JJ, Baker S. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis 2011, 5:e1163. 10.1371/journal.pntd.0001163, 3119645, 21713025.
12. Stuart BM, Pullen RL. Typhoid. Clinical analysis of three hundred and sixty cases. Arch Intern Med 1946, 78:629-661.
13. Scragg J, Rubidge C, Wallace HL. Typhoid fever in African and Indian children in Durban. Arch Dis Child 1969, 44:18-28. 10.1136/adc.44.233.18, 2020235, 4885537.
14. Duggan MB, Beyer L. Enteric fever in young Yoruba children. Arch Dis Child 1975, 1975(50):67-71.
15. Khan M, Coovadia YM, Connolly C, Sturm AW. Influence of sex on clinical features laboratory findings and complications of typhoid fever. Am J Trop Med Hyg 1999, 61:41-46.
16. Walia M, Gaind R, Mehta R, Paul P, Aggarwal P, Kalaivani M. Current perspectives of enteric fever: a hospital based study from India. Ann Trop Paed 2005, 25:161-174.
17. Wain J, Diep TS, Ho VA, Walsh AM, Hoa NTT, Parry CM, White NJ. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility and antimicrobial resistance. J Clin Microbiol 1998, 36:1683-1687. 104900, 9620400.
18. Hoa NTT, Diep TS, Wain J, Parry CM, Hien TT, Smith MD, Walsh AL, White NJ. Community acquired septicaemia in southern Vietnam: the importance of multidrug resistant Salmonella typhi. Trans Roy Soc Trop Med Hyg 1998, 92:503-508. 10.1016/S0035-9203(98)90891-4, 9861362.
19. Smith MD, Duong NM, Hoa NTT, Wain J, Ha HD, Diep TS, Day NPJ, Hien TT, White NJ. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994, 38:1716-1720. 10.1128/AAC.38.8.1716, 284627, 7986000.
20. Vinh H, Wain J, Hanh VTN, Nga CN, Chinh MT, Bethell D, Hoa NTT, Diep TS, Dung NM, White NJ. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother 1996, 40:958-961. 163238, 8849259.
21. Chinh NT, Solomon T, Thong MX, Ly LT, Hoa NTT, Wain J, Diep TS, Smith MD, Day NPJ, Phi LT, Parry CM, White NJ. Short courses of ofloxacin for the treatment of enteric fever. Trans R Soc Trop Med Hyg 1997, 91:347-349. 10.1016/S0035-9203(97)90102-4, 9231214.
22. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, Wain J, White NJ, Farrar JJ. A randomised controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid resistant enteric fever. Antimicrob Agents Chemother 2000, 44:1855-1859. 10.1128/AAC.44.7.1855-1859.2000, 89974, 10858343.
23. Wain J, Bay PVB, Vinh H, Duong NM, Diep TS, Walsh AL, Parry CM, Hasserjian RP, Ho VA, Hien TT, Farrar J, White NJ, Day NPJ. Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol 2001, 39:1571-1576. 10.1128/JCM.39.4.1571-1576.2001, 87972, 11283089.
24. Vinh H, Parry CM, Hanh VTN, Chinh MT, House D, Tham CT, Thao NTT, Diep TS, Wain J, Day NPJ, White NJ, Farrar JJ. Double blind comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever. Pediatr Infect Dis J 2004, 23:226-230. 10.1097/01.inf.0000114905.87426.c2, 15014297.
25. Chanh NQ, Everest P, Khoa TT, House D, Murch S, Parry CM, Connerton P, Bay PV, Diep TS, Mastroeni P, White NJ, Hien TT, Ho VA, Dougan G, Farrar JJ, Wain J. A clinical, microbiological, and pathological study of intestinal perforation associated with typhoid fever. Clin Infect Dis 2004, 39:61-67. 10.1086/421555, 15206054.
26. Vinh H, Duong NM, Phuong LT, Truong NT, Bay PVB, Wain J, Diep TS, Ho VA, White NJ, Day NPJ, Parry CM. Comparative trial of short course ofloxacin for uncomplicated typhoid fever in Vietnamese children. Ann Trop Paed 2005, 25:17-22.
27. Parry CM, Ho VA, Phuong LT, Bay PVB, Lanh MN, Tung LT, Tham NTH, Wain J, Hien TT, Farrar JJ. Randomised controlled comparison of ofloxacin, azithromycin and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid resistant typhoid fever. Antimicrob Agents Chemother 2007, 51:819-825. 10.1128/AAC.00447-06, 1803150, 17145784.
28. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: 23rd Informational Supplement. CLSI document M100-S23 33(1), Clinical and Laboratory Standards Institute 2013, PA: Wayne, Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: 23rd Informational Supplement. CLSI document M100-S23.
29. Ferreccio C, Levine MM, Manterola A, Rodriguez G, Rivara I, Prenzel I, Black RE, Mancuso T, Bulas D. Benign bacteraemia caused by Salmonella typhi and paratyphi in children younger than 2 years. J Pediatr 1984, 104:899-901. 10.1016/S0022-3476(84)80492-8, 6427437.
30. Topley JM. Mild typhoid fever in children. Arch Dis Child 1986, 61:164-167. 10.1136/adc.61.2.164, 1777598, 3954441.
31. Mahle WT, Levine MM. Salmonella typhi infection in children younger than five years of age. Pediatr Infect Dis J 1993, 12:627-631. 10.1097/00006454-199308000-00001, 8414773.
32. Kasper MR, Sokhal B, Blair PJ, Wierzba TF, Putnam SD. Emergence of multidrug- resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diag Micro Infect Dis 2010, 66:207-209.
33. Hoffman SL, Punjabi NH, Kumala S, Moechtar A, Pulungsih SP, Rivai RL, Rockhill RC, Woodward TE, Loedin AA. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high dose dexamethasone. N Engl J Med 1984, 310:82-88. 10.1056/NEJM198401123100203, 6361558.
34. Rogerson SJ, Spooner VJ, Smith TA, Richens J. Hydrocortisone in chloramphenicol treated severe typhoid fever in Papua New Guinea. Trans R Soc Trop Med Hyg 1991, 85:113-116. 10.1016/0035-9203(91)90180-7, 2068737.
35. Punjabi NH, Hoffman SL, Edman DC, Sukri N, Laughlin LW, Pulungsih SP, Rivai AR, Sutoto Moechtar A, Woodward TE. Treatment of severe typhoid fever in children with high dose dexamethasone. Ped Infect Dis J 1988, 7:598-600.
36. Thong KL, Passey M, Clegg A, Combs BG, Yassin RM, Pang T. Molecular analysis of isolates of Salmonella typhi obtained from patients with fatal and non-fatal typhoid fever. J Clin Microbiol 1996, 34:1029-1033. 228948, 8815078.
37. Thong KL, Goh YL, Yasin RM, Lau MG, Passey M, Winston G, Yoannes M, Pang T, Reeder JC. Increasing genetic diversity of Salmonella enterica serovar Typhi isolates from Papua New Guinea over the period from 1992 to 1999. J Clin Microbiol 2002, 40:4156-4160. 10.1128/JCM.40.11.4156-4160.2002, 139691, 12409390.
38. Phan MD, Kidgell C, Nair S, Holt KE, Turner AK, et al. Variation in Salmonella enterica serovar Typhi IncH1 plasmids during the global spread of resistant typhoid fever. Antimicrob Agents Chemother 2009, 53:716-727. 10.1128/AAC.00645-08, 2630618, 19015365.
39. Holt KE, Phan MD, Baker S, Duy PT, Nga TVT, Hinds J, Putcher P, Cooke FJ, Thomson NR, Titball R, Bhutta ZA, Hasan R, Dougan G, Wain J. Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis 2011, 5:e1245. 10.1371/journal.pntd.0001245, 3139670, 21811646.
40. Romagnac P, Weill FX, Dolecek C, Baker S, Brisse S, Chinh NT, Le TAH, Acosta CJ, Farrar J, Dougan G, Achtman M. Evolutionary history of Salmonella Typhi. Science 2006, 314:1301-1304. 10.1126/science.1134933, 2652035, 17124322.
41. Holt KE, Dolecek C, Chau TT, Duy PT, La TTP, Hoang NVM, Nga NVT, Campbell JI, Manh BH, Vinh Chau NV, Hien T, Farrar J, Dougan G, Baker S. Temporal fluctuation of multidrug resistant Salmonella Typhi haplotypes in the Mekong River Delta region of Vietnam. PLoS Neglect Trop Dis 2011, 5:e929.
42. Butler T. Treatment of typhoid fever in the 21st Century: promises and shortcomings. Clin Microbiol and Infect 2011, 17:959-963.